PPARA and metabolic dysfunction-associated steatotic liver disease: Interestingly, PPARα not only controls lipid catabolism and homeostasis, promoting fatty acid oxidation in the liver, but also stimulates glucose capture in the muscle.11 As such, regulation of PPARα by miR-21 in the muscle of NAFLD patients may be a relevant event promoting disease development and progression.